StockData
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. (CTKB) stock

CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/306% below fair value
$5.92+0.22 (+3.86%)

Close on Nov 18, 2026Market cap $769.50MP/E –Yield –

Cytek Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cytek Biosciences's pe ratio was 574.0× on Apr 28, 2023, against 728.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 2023574.0×−202.0
2022Oct 31, 2022776.0×−40.0
2021Dec 31, 2021816.0×–

More Cytek Biosciences figures

See a number that looks wrong?